Lupin announced the launch of Hydrocortisone Vale rate Cream USP, 0.2%, having received an approval from the United States Food and Drug
Administration (USFDA) earlier.
Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc. It is indicated for the re lief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients. Hydrocortisone Valerate Cream USP, 0.2%, (RLD: Westcort Cream) had an annual sales of approximately USD 11.5 million in the U.S. (IQVIA MAT September 2019).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
